Rohan Palekar - 16 Jan 2024 Form 4 Insider Report for Neurogene Inc. (NGNE)

Role
Director
Signature
/s/ Christine Mikail, as attorney-in-fact for Rohan Palekar
Issuer symbol
NGNE
Transactions as of
16 Jan 2024
Transactions value $
$0
Form type
4
Filing time
18 Jan 2024, 18:58:27
Previous filing
08 Jan 2024
Next filing
05 Feb 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NGNE Stock Option (Right to Buy) Award $0 +15.4K $0.00 15.4K 16 Jan 2024 Common Stock 15.4K $32.30 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option represents the right to purchase 15,400 shares of common stock of the Issuer, and vests in equal monthly installments through January 16, 2027, subject to the reporting person's continued service to the Issuer through each applicable vesting date.

Remarks:

Exhibit 24 - Power of Attorney